Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV003899122 | SCV004715002 | uncertain significance | PKHD1-related disorder | 2024-02-08 | criteria provided, single submitter | clinical testing | The PKHD1 c.6628G>C variant is predicted to result in the amino acid substitution p.Gly2210Arg. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. Of note, a different amino acid change affecting this residue has been reported with a pathogenic PKHD1 variant in an individual with autosomal recessive polycystic kidney disease (ARPKD) (c.6629G>A, p.Gly2210Glu in Gunay-Aygun et al. 2010. PubMed ID: 19914852). Although we suspect the c.6628G>C (p.Gly2210Arg) variant is pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |